MOTS-c vs Semaglutide.
Quick Verdict
MOTS-c is a mitochondrial peptide primarily researched for energy, metabolism, fat loss, longevity, while Semaglutide is a glp-1 agonist studied for fat loss, appetite control, cardiovascular benefits. A key distinction: Semaglutide has FDA approval status.
Side-by-Side Analysis
| Dimension | MOTS-c | Semaglutide |
|---|---|---|
| Category | Mitochondrial Peptide | GLP-1 Agonist |
| Mechanism | Regulates mitochondrial function and AMPK. | GLP-1 receptor agonism mimics the incretin hormone to reduce appetite, slow gastric emptying, improve insulin sensitivity, and provide cardiovascular protection. |
| Half-Life | ~4 hours | ~7 days |
| Route | SubQ | SubQ |
| Typical Dose | 2000–2000 mcg | 250–250 mcg |
| Frequency | 5x/week | 1x/wk |
| Evidence Level | Emerging | Very Strong |
| Indexed Studies | 20+ indexed | 20+ indexed |
| FDA Status | Research Only | Approved |
| Lowest Price | $39.99 / 10mg via Amino Club | $47.99 / 5mg via Amino Club |
| Per-mg Cost | $4.00/mg | $9.60/mg |
Mechanism of Action Comparison
How MOTS-c Works
MOTS-c MOTS-c is a peptide encoded in mitochondrial DNA studied for improving insulin sensitivity, boosting exercise performance, and protecting against the metabolic decline that comes with aging.
Regulates mitochondrial function and AMPK. Enhances glucose uptake and fatty acid oxidation, improves insulin sensitivity, and protects against age-related metabolic decline.
How Semaglutide Works
Semaglutide Semaglutide is an FDA-approved GLP-1 receptor agonist used to treat type 2 diabetes (Ozempic) and obesity (Wegovy), reducing appetite and improving blood sugar control.
GLP-1 receptor agonism mimics the incretin hormone to reduce appetite, slow gastric emptying, improve insulin sensitivity, and provide cardiovascular protection.
Key Mechanistic Difference
MOTS-c operates as a mitochondrial peptide, while Semaglutide functions as a glp-1 agonist — these are fundamentally different pharmacological approaches. Semaglutide has a significantly longer half-life (~7 days) compared to MOTS-c (~4 hours), which impacts dosing frequency and sustained activity.
Research Evidence
MOTS-c
20 studies- MOTS-c regulates metabolic homeostasis (Cell Metabolism)Lee et al. (Cell Metabolism): Discovery paper showing MOTS-c is a mitochondrial-derived peptide that regulates insulin s…Emerging
- MOTS-c prevents age-related insulin resistance in miceLee et al.: MOTS-c treatment prevents both age-dependent and high-fat-diet-induced insulin resistance and diet-induced o…Preclinical
- MOTS-c improves skeletal muscle glucose metabolismStudy demonstrating MOTS-c specifically targets skeletal muscle glucose metabolism, providing molecular basis for metabo…Preclinical
Semaglutide
20 studies- STEP 1: Semaglutide 2.4 mg for weight managementWilding et al. (NEJM): Landmark STEP 1 trial semaglutide 2.4mg achieved 14.9% mean weight loss vs 2.4% placebo at 68 w…Very Strong
- SELECT trial: semaglutide reduces cardiovascular events by 20%Lincoff et al. (NEJM): SELECT trial shows semaglutide 2.4mg reduces major adverse cardiovascular events by 20% in overwe…Very Strong
- STEP program overview: pooled Phase 3 weight loss dataComprehensive analysis across STEP trials showing 14.9-17.4% weight loss, improved cardiometabolic risk factors, blood p…Very Strong
Vendor Pricing
· Affiliate links · Prices verified 2026MOTS-c
4 vendorsSemaglutide
2 vendorsAffiliate disclosure: PeptiDex may earn a commission from purchases via vendor links at no extra cost to you. See our methodology.
Frequently Asked Questions
Can I take MOTS-c and Semaglutide together?▼
No direct interaction data is available for this specific pair. They target different receptor systems, suggesting they could potentially be combined, but no published protocol validates this combination.
Which has more research evidence — MOTS-c or Semaglutide?▼
MOTS-c has 20 indexed studies (highest evidence: Emerging). Semaglutide has 20 indexed studies (highest evidence: Very Strong). Both have comparable research coverage.
What is the price difference between MOTS-c and Semaglutide?▼
At current verified vendor prices, MOTS-c starts at $4.00/mg while Semaglutide starts at $9.60/mg. Prices vary by vendor and vial size — see the full vendor comparison below.
Which is better for fat loss — MOTS-c or Semaglutide?▼
Both are researched for fat loss. MOTS-c addresses this via energy, metabolism, fat loss, longevity. Semaglutide approaches it through fat loss, appetite control, cardiovascular benefits. The optimal choice depends on your specific research protocol and which mechanism aligns with your objectives.
Is MOTS-c or Semaglutide FDA-approved?▼
Semaglutide has FDA approval (or is derived from an FDA-approved compound). MOTS-c is a research compound without FDA approval for human use. FDA status reflects regulatory evaluation — not necessarily superiority for all research applications.
Related Comparisons
Deep Dive Profiles
Shared Research Goals
Research Use Only — Not Medical Advice
This comparison is provided for educational and research purposes only. It does not constitute medical, prescribing, or treatment advice. Clinical data cited here is sourced from published peer-reviewed trials and FDA labels. Consult a qualified healthcare professional before making any decisions about medications or research compounds. PeptiDex is an informational resource and does not sell pharmaceutical products.